Sachs, David P.L.

Sustained-Release Bupropion for Pharmacologic Relapse Prevention after Smoking Cessation: A Randomized, Controlled Trial

Hays, J. T., Hurt, R. D., Rigotti, N. A., Niaura, R., Gonzales, D., Durcan, M. J., Sachs, D. P. L., Wolter, T. D., Buist, A. S., Johnston, J. A., et al. (2001) · Annals of Internal Medicine

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 343

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism∗

Hayford, K. E., Patten, C. A., Rummans, T. A., Schroeder, D. R., Offord, K. P., Croghan, I. T., Glover, E. D., Sachs, D. P. L., & Hurt, R. D. (1999) · British Journal of Psychiatry

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 264

Bupropion for Smoking Cessation

Dale, L. C., Glover, E. D., Sachs, D. P. L., Schroeder, D. R., Offord, K. P., Croghan, I. T., & Hurt, R. D. (2001) · Chest

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 177

Effectiveness of the 4-mg Dose of Nicotine Polacrilex for the Initial Treatment of High-Dependent Smokers

Sachs, D. P. L. (1995) · Archives of Internal Medicine

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 56

Nicotine polacrilex dose effects: serum nicotine levels and sensory characteristics

Leischow, S. J., Sachs, D. P. L., Hansen, M. D., & Bostrom, A. G. (1995) · Psychopharmacology

Smoking Behavior and CessationInhalation and Respiratory Drug Delivery

Cited by 6